CHAIN Biotech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Liquidation

CHAIN Biotech General Information

Description

Developer of a proprietary microbial platform designed to help in drug delivery. The company's platform involves the development and use of engineered clostridia to deliver specific therapeutics to the gut and supports a product pipeline for a wide range of clinical indications, including localized infections, inflammation, and central nervous system signaling, enabling patients to get an engineered strain that secretes a novel and potent anti-inflammatory molecule targeting inflammatory bowel disease and chronic gut disease.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Level 1 Bessemer Building
  • Imperial College London
  • London SW7 2AZ
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Level 1 Bessemer Building
  • Imperial College London
  • London SW7 2AZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CHAIN Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Bankruptcy: Liquidation 23-Jul-2026 Completed Bankruptcy: Liquidation
8. Seed Round 09-Jun-2023 Completed Generating Revenue
7. Seed Round 10-Sep-2021 Completed Pre-Clinical Trials
6. Seed Round 01-Nov-2018 Completed Pre-Clinical Trials
5. Grant 12-Sep-2017 Completed Pre-Clinical Trials
4. Seed Round 03-Apr-2017 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Seed Round 23-Dec-2015 $199K $199K Completed Pre-Clinical Trials
1. Grant 16-Oct-2015 $299K Completed Pre-Clinical Trials
To view CHAIN Biotech’s complete valuation and funding history, request access »

CHAIN Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 154,451 $0.001244 $5.19 $5.19 1x $5.19 9.06%
Ordinary 51,800 $0.001244 $3.17 $3.17 1x $3.17 3.04%
To view CHAIN Biotech’s complete cap table history, request access »

CHAIN Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proprietary microbial platform designed to help in drug delivery. The company's platform involves the dev
Drug Delivery
London, United Kingdom
9 As of 2026

San Diego, CA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CHAIN Biotech Competitors (18)

One of CHAIN Biotech’s 18 competitors is Bloom Science, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bloom Science Venture Capital-Backed San Diego, CA
Thabor Therapeutics Venture Capital-Backed Paris, France
EverImmune Venture Capital-Backed Villejuif, France
Nextera Venture Capital-Backed Oslo, Norway
GlycosBio Venture Capital-Backed Houston, TX
You’re viewing 5 of 18 competitors. Get the full list »

CHAIN Biotech Patents

CHAIN Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202209115-D0 Compositions and methods Inactive 21-Jun-2022
WO-2023247936-A1 Compositions and methods Inactive 21-Jun-2022
AU-2021404131-A1 Compositions and methods Pending 15-Dec-2020
CA-3202257-A1 Compositions and methods Pending 15-Dec-2020
EP-4262861-A1 Compositions and methods Pending 15-Dec-2020 A61K39/107
To view CHAIN Biotech’s complete patent history, request access »

CHAIN Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CHAIN Biotech FAQs

  • When was CHAIN Biotech founded?

    CHAIN Biotech was founded in 2014.

  • Where is CHAIN Biotech headquartered?

    CHAIN Biotech is headquartered in London, United Kingdom.

  • What is the size of CHAIN Biotech?

    CHAIN Biotech has 9 total employees.

  • What industry is CHAIN Biotech in?

    CHAIN Biotech’s primary industry is Drug Delivery.

  • Is CHAIN Biotech a private or public company?

    CHAIN Biotech is a Private company.

  • What is CHAIN Biotech’s current revenue?

    The current revenue for CHAIN Biotech is .

  • How much funding has CHAIN Biotech raised over time?

    CHAIN Biotech has raised $5.29M.

  • Who are CHAIN Biotech’s competitors?

    Bloom Science, Thabor Therapeutics, EverImmune, Nextera, and GlycosBio are some of the 18 competitors of CHAIN Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process